Usefulness of second (131)I treatment in biochemical persistent differentiated thyroid cancer patients

BACKGROUND: Second (131)I treatment is commonly performed in clinical practice in patients with differentiated thyroid cancer and biochemical incomplete or indeterminate response (BiR/InR) after initial treatment. OBJECTIVE: The objective of the is study is to evaluate the clinical impact of the sec...

Descripción completa

Detalles Bibliográficos
Autores principales: Gambale, Carla, Prete, Alessandro, Contartese, Lea, Torregrossa, Liborio, Bianchi, Francesca, Molinaro, Eleonora, Materazzi, Gabriele, Elisei, Rossella, Matrone, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620453/
https://www.ncbi.nlm.nih.gov/pubmed/37855417
http://dx.doi.org/10.1530/ETJ-23-0052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620453/
https://www.ncbi.nlm.nih.gov/pubmed/37855417
http://dx.doi.org/10.1530/ETJ-23-0052

Ejemplares similares